Inato
FranceWho owns Inato?
Inato is a French Biotech company, currently owned by La Maison Partners since 2023 and 5 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by Elaia Partners, Fly Ventures, Cathay Capital, Serena Capital, La Maison Partners and Lazard Elaia Capital since 2017.
- ·6 distinct PE sponsors across ownership cycles.
Ownership history
6 ownership periods · co-invest detected
More from Lazard Elaia Capital Fund I
Other portfolio companies in the same fund.
USAMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Questions
Who owns Inato?
Inato is currently owned by La Maison Partners, Cathay Capital and 4 others, through Lazard Elaia Capital Fund I, since 2023.
When did La Maison Partners and 5 others acquire Inato?
La Maison Partners and 5 others acquired Inato in 2023.
Who has owned Inato over time?
Inato has been through 6 private-equity ownership periods: Elaia Partners · via Elaia Delta Fund · since 2017; Fly Ventures · via Fly Ventures Fund I · since 2017; Cathay Capital · via Cathay Innovation Fund II · since 2019; Serena Capital · via Racine² · since 2019; La Maison Partners · via La Maison NextGen · since 2023; Lazard Elaia Capital · via Lazard Elaia Capital Fund I.